Saturday, March 29, 2025
Washington, October 1, 2025 – U.S. President Donald Trump announced a major initiative on Tuesday by signing a new executive order directing the use of artificial intelligence (AI) to accelerate research on childhood cancer. The move, unveiled at the White House in the presence of media, is aimed at harnessing advanced technology to fight one of the deadliest diseases affecting children worldwide.
Speaking after the signing, President Trump emphasized that AI could play a transformative role in both cancer research and treatment. “Artificial intelligence will help us supercharge pediatric cancer research and bring hope to thousands of families,” Trump said, calling the order a decisive step in America’s fight against the disease.
Trump explained that in 2019, he instructed officials to begin systematically collecting data on pediatric cancer cases across the country. When the findings were presented, he was deeply disturbed by the scale and impact of the disease. This prompted him to push for stronger measures to reduce its burden on American families.
The new executive order builds on a report prepared by Health Department officials Robert F. Kennedy Jr. and the MAHA Commission, which recommended expanded federal investment in childhood cancer research. Trump has now endorsed those recommendations and ordered that AI tools be fully integrated into ongoing studies.
According to the White House, the order mandates federal agencies to collaborate with research institutes and healthcare providers to apply AI-driven models in identifying cancer patterns, developing new therapies, and speeding up clinical trials. The administration claims this approach will shorten the timeline for potential breakthroughs and improve survival rates among children.
The initiative is part of a broader series of executive actions President Trump has rolled out in recent weeks, reflecting his administration’s push to showcase rapid policy measures across healthcare, trade, and technology.
